Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
ImmuCell Corporation
ICCC ยท SEC Filings
website
73
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufac...
Price
10.22
Market Cap
94.02 M
Float
5.77 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about ICCC
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
ImmuCell Corporation
ICCC ยท SEC Filings
5.77 M
Float
10.22
Price
94.02 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2026
10-K/A
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
May 13, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2025
News
TYPE
HEADLINE
FILED AT
8-K
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026
Oct 13, 2026
8-K
ImmuCell Reports Second Quarter 2026 Financial Results and Capacity Expansion Plans
Aug 13, 2026
8-K
ImmuCell Reports Preliminary Q2 2026 Sales Growth of 11.5% and Six-Month Growth of 20.9%
Jul 9, 2026
8-K
ImmuCell Corporation Announces Results of 2026 Annual Meeting of Stockholders
Jun 17, 2026
8-K
ImmuCell Corporation Authorizes Manufacturing Capacity Expansion for First Defenseยฎ Product Line
Jun 10, 2026
8-K
ImmuCell Reports Strong First Quarter 2026 Financial Results
May 14, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B2
Common Stock
Apr 9, 2024
424B2
Common Stock
Apr 9, 2024
424B5
SHELF OFFERING | Shares amount: 515,156 | Share price: $8.25 | Offering amount: $4,250,037.00 | Float: 7,220,836 | Amount sold to date: $0.00
Apr 16, 2021
424B5
$9,000,002 of Shares of Common Stock
Mar 27, 2019
424B5
$ of Shares of Common Stock
Mar 26, 2019
424B3
Common Stock
Nov 29, 2018
Registrations
TYPE
HEADLINE
FILED AT
S-3
SHELF | ATM | Offering amount: $20,000,000.00 EFFECTIVE
Apr 1, 2024
S-8
Registration
Jul 13, 2023
S-8
Registration
Mar 27, 2020
S-3
Common Stock
Nov 20, 2018
S-3/A
659,880 Shares of
Dec 5, 2016
S-3
659,880 Shares of
Nov 16, 2016
Proxies
TYPE
HEADLINE
FILED AT
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 24, 2026
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Apr 14, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 24, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 26, 2024
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 28, 2023
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Apr 18, 2023
Ownerships
TYPE
HEADLINE
FILED AT
4
te Boekhorst Paul Francis Olivier (Reporting)
Jun 22, 2026
3
DiMarco Anthony (Reporting)
Apr 23, 2026
3
Guillemette Gilles (Reporting)
Apr 23, 2026
4
Turner Kathy V (Reporting)
Apr 16, 2026
4
Tomsche David Scott (Reporting)
Apr 16, 2026
4
Basse Gloria F (Reporting)
Apr 16, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 10, 2024
CORRESP
Form CORRESP - Correspondence
Apr 5, 2024
LETTER
Form UPLOAD - SEC-generated letter
Apr 5, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
Nov 30, 2018
CORRESP
Form CORRESP - Correspondence
Nov 28, 2018
LETTER
Form UPLOAD - SEC-generated letter
Nov 26, 2018
